TY - JOUR
T1 - Universal MI definition update for cardiovascular disease
AU - White, Harvey
AU - Thygesen, Kristian
AU - Alpert, Joseph S.
AU - Jaffe, Allan
N1 - Funding Information:
Conflict of Interest Harvey White has received research grants from Sanofi Aventis; Eli Lilly; Medicines Company; NIH; Pfizer; Roche; Johnson & Johnson; Schering Plough; Merck Sharpe & Dohme; AstraZeneca; GlaxoSmithKline; Daiichi Sankyo Pharma Development and Bristol-Myers Squibb and has served on Advisory boards for Merck Sharpe & Dohme, Roche, AstraZeneca, and Regado Biosciences. Kristian Thygesen declares that he has no conflict of interest.
PY - 2014/6
Y1 - 2014/6
N2 - The new third universal definition of myocardial infarction (MI) is based on troponin elevation together with ischemic symptoms, ischemic ECG changes, and imaging evidence. MIs are classified into five types as to whether they are spontaneous, secondary to imbalance between coronary artery blood supply and demand, related to sudden death, or related to revascularization procedures. The definition is based on a rise and/or fall in troponin levels occurring in a clinical setting. There have been modifications over previous definitions with adding intracoronary thrombus as a criterion, adding a new type of MI type 4c, and raising the cutpoint for the diagnosis of MI related to percutaneous coronary intervention to five times the 99th percentile upper reference limit and requiring evidence of ischemia or angiographic complications. In clinical practice, trials, and registries, different definitions are used. There is a need for consistency with regard to the definition of MI and the universal definition should be implemented.
AB - The new third universal definition of myocardial infarction (MI) is based on troponin elevation together with ischemic symptoms, ischemic ECG changes, and imaging evidence. MIs are classified into five types as to whether they are spontaneous, secondary to imbalance between coronary artery blood supply and demand, related to sudden death, or related to revascularization procedures. The definition is based on a rise and/or fall in troponin levels occurring in a clinical setting. There have been modifications over previous definitions with adding intracoronary thrombus as a criterion, adding a new type of MI type 4c, and raising the cutpoint for the diagnosis of MI related to percutaneous coronary intervention to five times the 99th percentile upper reference limit and requiring evidence of ischemia or angiographic complications. In clinical practice, trials, and registries, different definitions are used. There is a need for consistency with regard to the definition of MI and the universal definition should be implemented.
KW - Cardiovascular disease
KW - Myocardial infarction
KW - Troponin
KW - Universal definition
UR - http://www.scopus.com/inward/record.url?scp=84901305360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901305360&partnerID=8YFLogxK
U2 - 10.1007/s11886-014-0492-5
DO - 10.1007/s11886-014-0492-5
M3 - Review article
C2 - 24803385
AN - SCOPUS:84901305360
SN - 1523-3782
VL - 16
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 6
M1 - 492
ER -